| Multidrug-resistant HIV-1 RNA and proviral DNA variants harboring new dipeptide insertions in the reverse transcriptase pol gene. |
Andréoletti L, Weiss L, Si-Mohamed A, Piketty C, Prazuck T, Calamy G, Malkin JE, Matta M, Mbopi-Kéou FX, Clavel F, Kazatchkine MD, Bélec L |
2002 |
| Causal pathways of the effects of age and the CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on AIDS development. |
Geskus RB, Meyer L, Hubert JB, Schuitemaker H, Berkhout B, Rouzioux C, Theodorou ID, Delfraissy JF, Prins M, Coutinho RA |
2005 |
| Emergence of zidovudine resistance in HIV-infected patients receiving stavudine. |
de Mendoza C, Soriano V, Briones C, Gallego O, Barreiro P, Alvarez A, González-Lahoz J |
2000 |
| A novel genotype encoding a single amino acid insertion and five other substitutions between residues 64 and 74 of the HIV-1 reverse transcriptase confers high-level cross-resistance to nucleoside reverse transcriptase inhibitors. Abacavir CNA2007 International Study Group. |
Rakik A, Ait-Khaled M, Griffin P, Thomas TA, Tisdale M, Kleim JP |
1999 |
| Characterization of HIV isolates arising after prolonged zidovudine therapy. |
Mayers DL, McCutchan FE, Sanders-Buell EE, Merritt LI, Dilworth S, Fowler AK, Marks CA, Ruiz NM, Richman DD, Roberts CR |
1992 |
| Effect of nonviable preparations from human immunodeficiency virus type 1 on nuclear matrix-associated DNA polymerase alpha and DNA topoisomerase II activities. |
Müller WE, Matthes E, Reuter P, Wenger R, Friese K, Kuchino Y, Schröder HC |
1990 |